Optimal selection of STEMI treatment strategies in the current ERA: Benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy

Current Opinion in Cardiology

Volumn 27, Issue 6, 2012, Pages 651-654

  Chakrabarti, Anjan K ^a   Gibson, C Michael ^a   Pinto, Duane S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

door to balloon time; fibrinolytics; percutaneous coronary intervention; ST elevation myocardial infarction

Indexed keywords

FIBRINOLYTIC AGENT;

CARDIOVASCULAR MORTALITY; CORONARY REPERFUSION; FIBRINOLYTIC THERAPY; HOSPITAL DISCHARGE; HUMAN; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGIONALIZATION; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STANDARDIZATION;

FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PATIENT TRANSFER; PERCUTANEOUS CORONARY INTERVENTION; TIME FACTORS;

EID: 84868300453     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e3283587c69     Document Type: Review

References (27)

1. Nallamothu BK, Antman EM, Bates ER. Primary percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: Does the choice of fibrinolytic agent impact on the importance of time-to-treatment? Am J Cardiol 2004; 94:772-774.
2. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: Is timing (almost) everything? Am J Cardiol 2003; 92:824-826.
3. Boden WE, Gupta V. Reperfusion strategies in acute ST-segment elevation myocardial infarction. Curr Opin Cardiol 2008; 23:613-619.
4. Gibson CM, Pride YB, Frederick PD, et al. Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J 2008; 156:1035-1044.
5. Nallamothu BK, Bates ER, Herrin J, et al. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis. Circulation 2005; 111:761-767.
6. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: A meta-analysis. Circulation 2003; 108:1809-1814.
7. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onsetto-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000; 283:2941-2947.
8. De LucaG, Biondi-Zoccai G, Marino P. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: A meta-regression analysis of randomized trials. Ann Emerg Med 2008; 52:665-676.
9. Magid DJ, Calonge BN, Rumsfeld JS, et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 2000; 284:3131-3138.
10. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: Implications when selecting a reperfusion strategy. Circulation 2006; 114:2019-2025.
11. Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future? JAMA 2005; 293:979-986.
12. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 51:210-247.
13. Chakrabarti A, Krumholz HM, Wang Y, et al. Time-to-reperfusion in patients undergoing interhospital transfer for primary percutaneous coronary intervention in the U.S: An analysis of 2005 and 2006 data from the National Cardiovascular Data Registry. J Am Coll Cardiol 2008; 51:2442-2443.
14. Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring STsegment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation 2011; 124:2512-2521.
15. Nallamothu BK, Bates ER, Wang Y, et al. Driving times and distances to hospitals with percutaneous coronary intervention in the United States: Implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 2006; 113:1189-1195.
16. Concannon TW, Nelson J, Goetz J, Griffith JL. A percutaneous coronary intervention lab in every hospital? Circ CardiovascQualOutcomes 2012; 5:14-20.
17. Jacobs AK, Antman EM, Ellrodt G, et al. Recommendation to develop strategies to increase the number of ST-segment-elevation myocardial infarction patients with timely access to primary percutaneous coronary intervention. Circulation 2006; 113:2152-2163.
18. Pollack CV Jr, Diercks DB, Roe MT, Peterson ED. 2004 American College of Cardiology/American Heart Association guidelines for the management of patients with ST-elevation myocardial infarction: Implications for emergency department practice. Ann Emerg Med 2005; 45:363-376.
19. Henry TD, Unger BT, Sharkey SW, et al. Design of a standardized system for transfer of patients with ST-elevation myocardial infarction for percutaneous coronary intervention. Am Heart J 2005; 150:373-384.
20. Jollis JG, Roettig ML, Aluko AO, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA 2007; 298:2371-2380.
21. Krumholz HM, Anderson JL, Bachelder BL, et al. ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-STElevation Myocardial Infarction) Developed in Collaboration With the American Academy of Family Physicians and American College of Emergency Physicians Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, Society for Cardiovascular Angiography and Interventions, and Society of Hospital Medicine. J Am Coll Cardiol 2008; 52:2046-2099.
22. Herrin J, Miller LE, Turkmani DF, et al. National performance on door-in to door-out time among patients transferred for primary percutaneous coronary intervention. Arch Intern Med 2011; 171:1879-1886.
23. Glickman SW, Granger CB, Ou FS, et al. Impact of a statewide ST-segmentelevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly. Circ Cardiovasc Qual Outcomes 2010; 3:514-521.
24. Dauerman HL, Sobel BE. Toward a comprehensive approach to pharmacoinvasive therapy for patients with ST segment elevation acute myocardial infarction. J Thromb Thrombolysis 2012; 34:180-186.
25. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet 2006; 367:569-578.
26. Ellis SG, Tendera M, de Belder MA, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358:2205-2217.
27. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31:2501-2555.